Tags: Diagnostics Accelerator

announcements

The ADDF Announces New Research Initiative to Advance Digital Tools for Detection for Alzheimer's

The ADDF's Diagnostics Accelerator is seeking to fund the development of digital tools to capture quantifiable biomarkers.

blog

Top 5 Advances in 2018

In 2018 we have seen increased investments in Alzheimer's biomarkers and increased interest in prevention.

announcements

The ADDF's Diagnostics Accelerator Initiative Expands Its Focus on Frontotemporal Degeneration

The ADDF's Diagnostics Accelerator is matching a $2.5 million research investment from The Association for Frontotemporal Degeneration to invest in biomarkers for frontotemporal dementia.

blog

Two Decades of Research: The ADDF's 19th International Conference on Alzheimer’s Drug Discovery

Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.

announcements

19th International Conference on Alzheimer's Drug Discovery Highlights Multiple Approaches

The conference, organized by the Alzheimer's Drug Discovery Foundation, focused on gene therapy and alternative modalities for neurodegenerative diseases, progress in developing novel drugs, as well as the need for new biomarkers.

announcements

New Coalition of Philanthropists Including Bill Gates, Leonard Lauder Commit More Than $30 Million

Bill Gates and Leonard Lauder have announced Diagnostics Accelerator, an initiative to develop new biomarkers for early detection for Alzheimer's.